Clinical Trial Update: The Safety and The Efficacy Evaluation of NEUROSTEM®-AD in Patients With Alzheimer's Disease [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating safety and efficacy of NEUROSTEM-AD in Alzheimer's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• NEUROSTEM-AD

Snippet

Sponsor: Medipost Co Ltd. | Conditions: Dementia of the Alzheimer's Type | Phase 1 | Status: COMPLETED